Back to search
FDAFDA · Food and drugs·Recall number D-1335-2022

Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02

Published August 24, 2022 · Recall initiated: August 2, 2022

Summary

FDA records drug Class III recall D-1335-2022, published August 24, 2022 and initiated August 2, 2022. Recalling firm: HERON THERAPEUTICS, INC.; Status: Terminated; Reported quantity: 1790 kits; Lot: Lot #: 01126739, Exp 7/31/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit

What to do

Voluntary: Firm initiated · Letter

Get an email if ZYNRELEF has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ZYNRELEF
Manufacturer
HERON THERAPEUTICS, INC.
Distributor
U.S.A. Nationwide
Lot
Lot #: 01126739, Exp 7/31/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02 recalled?

Yes. FDA published recall D-1335-2022 on August 24, 2022. Reported hazard: Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZYNRELEF.